查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
组织诊断市场、份额、规模、趋势、行业分析报告：按产品、技术、疾病、应用、地区、细分市场预测，2024-2032
市场调查报告书
商品编码
1421730

组织诊断市场、份额、规模、趋势、行业分析报告：按产品、技术、疾病、应用、地区、细分市场预测，2024-2032

Tissue Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product ; By Technology; By Disease ; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球组织诊断市场规模预计将达到 101.8 亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

组织诊断在医学领域发挥重要作用，可以透过分析组织样本来诊断癌症和其他疾病。 在使用的各种技术中，苏木精和伊红染色 (H&E) 被广泛认为是病理学家评估潜在癌症病例时的黄金标准。 癌症诊断和监测是组织诊断的主要用途，但它们也可用于诊断其他疾病。 该领域对个人化医疗寄予厚望，为不同类型的癌症提供量身定制的治疗方法。

组织诊断可用于开发标靶治疗并改善患者预后。 此外，它还有助于预防疾病復发。 例如，2023 年 1 月，国际癌症研究机构 (IARC) 发布了综合数位指南《乳癌早期检测图集》。 它提供了临床乳房检查、诊断性乳房X光检查、诊断性乳房超音波、细针抽吸细胞学和核心乳房活检的逐步方法。

对个人化医疗的日益重视正在推动对基于组织的诊断测试的需求，以帮助选择和监测标靶治疗。 数位病理测试和自动化等技术进步正在提高组织诊断的效率和准确性。 此外，人们对多重检测越来越感兴趣，它可以同时分析单一组织样本中的多个生物标记。 此外，产业参与者之间的伙伴关係和协作正在推动创新和全面解决方案的开发。 人工智慧和机器学习在组织诊断中的整合有望透过实现自动化分析和预测功能来彻底改变该领域。

组织诊断市场报告亮点

  • 消耗品业务预计将在预测期内保持最高成长。
  • 免疫组化领域将在 2022 年占据最大的市场销售份额，因为免疫组化可以以更高的特异性区分肿瘤类型。
  • 到 2022 年，医院产业将占据市场最大的销售份额。 原因是，由于效率和可用性的提高，医生正在采用组织诊断测试技术而不是传统方法。
  • 得益于旨在降低癌症发病率的癌症预防和控制研究网络等公共项目，北美在 2022 年占据了最大的市场销售份额。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第 4 章全球组织诊断市场洞察

  • 组织诊断 - 行业概况
  • 组织诊断市场动态
    • 推动者和机会
      • 影像技术的进步和诊断负担能力的提高
      • 个人化治疗与诊断的发展
    • 抑制因素和挑战
      • 与研发和临床试验相关的高昂成本
  • 杵分析
  • 组织诊断产业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球组织诊断市场（按技术）

  • 主要调查结果
  • 简介
  • 原位杂交
  • 初级染色和特殊染色
  • 免疫组织化学
  • 数位病理学
  • 其他

第 6 章全球组织诊断市场（按产品）

  • 主要调查结果
  • 简介
  • 设备
  • 消耗品

第七章依疾病划分的全球组织诊断市场

  • 主要调查结果
  • 简介
  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 皮肤癌
  • 其他

第 8 章全球组织诊断市场，依最终用途划分

  • 主要调查结果
  • 简介
  • 医院
  • 研究
  • 合约研究组织
  • 製药公司
  • 其他

第 9 章全球组织诊断市场（按地区）

  • 主要调查结果
  • 简介
    • 2019-2032 年组织诊断市场评估，地区
  • 组织诊断市场 - 北美
    • 北美：组织诊断市场（按技术），2019-2032 年
    • 北美：组织诊断市场（依最终用途），2019-2032 年
    • 北美：组织诊断市场（按产品），2019-2032 年
    • 北美：组织诊断市场，依疾病分类，2019-2032 年
    • 组织诊断市场-美国
    • 组织诊断市场 - 加拿大
  • 组织诊断市场 - 欧洲
    • 欧洲：组织诊断市场（按技术），2019-2032 年
    • 欧洲：组织诊断市场（依最终用途），2019-2032 年
    • 欧洲：组织诊断市场（按产品），2019-2032 年
    • 欧洲：组织诊断市场，依疾病分类，2019-2032 年
    • 组织诊断市场 - 英国
    • 组织诊断市场 - 法国
    • 组织诊断市场-德国
    • 组织诊断市场-义大利
    • 组织诊断市场 - 西班牙
    • 组织诊断市场 - 荷兰
    • 组织诊断市场-俄罗斯
  • 组织诊断市场 - 亚太地区
    • 亚太地区：组织诊断市场（按技术），2019-2032 年
    • 亚太地区：组织诊断市场（依最终用途），2019-2032 年
    • 亚太地区：组织诊断市场（按产品），2019-2032 年
    • 亚太地区：组织诊断市场（依疾病），2019-2032 年
    • 组织诊断市场—中国
    • 组织诊断市场-印度
    • 组织诊断市场—日本
    • 马来西亚组织诊断市场
    • 组织诊断市场-印尼
    • 组织诊断市场—韩国
  • 组织诊断市场 - 中东/非洲
    • 中东和非洲：组织诊断市场（按技术），2019-2032 年
    • 中东和非洲：组织诊断市场（以最终用途），2019-2032 年
    • 中东和非洲：组织诊断市场（按产品），2019-2032 年
    • 中东和非洲：组织诊断市场（按疾病），2019-2032 年
    • 组织诊断市场 - 沙乌地阿拉伯
    • 组织诊断市场 - 南非
    • 组织诊断市场 - 以色列
    • 组织诊断市场 - 阿拉伯联合大公国
  • 组织诊断市场 - 拉丁美洲
    • 拉丁美洲：组织诊断市场（按技术），2019-2032 年
    • 拉丁美洲：组织诊断市场（依最终用途），2019-2032 年
    • 拉丁美洲：组织诊断市场（按产品），2019-2032 年
    • 拉丁美洲：组织诊断市场，依疾病分类，2019-2032 年
    • 组织诊断市场 - 墨西哥
    • 组织诊断市场 - 巴西
    • 组织诊断市场 - 阿根廷

第10章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第11章公司简介

  • Abbott
  • Agilent Technologies, Inc.
  • Bio SB
  • BioGenex
  • Becton, Dickinson and Company（BD）
  • Cell Signaling Technology, Inc.
  • Danaher
  • GE Healthcare
  • Histo-Line Laboratories
  • Hologic Inc
  • Merck KGAA
  • Metropolis Healthcare Limited
  • Roche
  • SAKURA FINETEK JAPAN CO., LTD
  • SLEE Medical GMBH
  • Thermo Fisher Scientific Inc.
Product Code: PM4060

The global tissue diagnostics market size is expected to reach USD 10.18 billion by 2032, according to a new study by Polaris Market Research. The report "Tissue Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Technology; By Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Skin Cancer, Others); By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Tissue diagnostics play a crucial role in the medical field, enabling the analysis of tissue samples to diagnose cancer and other disorders. Among the various techniques used, hematoxylin and eosin stain (H&E) is widely regarded as the gold standard by pathologists when evaluating potential cancer cases. While cancer diagnosis and monitoring are the primary applications of tissue diagnostics, they can also be utilized for diagnosing other diseases. This field holds great promise for personalized medicine, offering tailored treatment options for different types of cancers.

By leveraging tissue diagnostics, targeted therapies can be developed, improving patient outcomes. Furthermore, it aids in preventing disease relapses. For instance, In January 2023, The International Agency for Research on Cancer (IARC) introduced the Atlas of Breast Cancer Early Detection, a comprehensive digital guide. It provides a step-by-step approach to clinical breast examination, diagnostic mammography, diagnostic breast ultrasound, fine-needle aspiration cytology, and core breast biopsy.

A growing emphasis on personalized medicine has increased demand for tissue-based diagnostic tests that aid in targeted treatment selection and monitoring. Technological advancements, such as digital pathology and automation, are improving the efficiency and accuracy of tissue diagnostics. Additionally, a rising focus on multiplex assays enables the simultaneous analysis of multiple biomarkers in a single tissue sample. Furthermore, partnerships and collaborations between industry players drive innovation and comprehensive solutions development. Integrating artificial intelligence and machine learning in tissue diagnostics is poised to revolutionize the field by enabling automated analysis and predictive capabilities.

Tissue Diagnostics Market Report Highlights

  • Consumables segment is anticipated to hold the highest growth during the forecast period, due to these are the products are implemented for reliable and accurate tissue analysis.
  • Immunohistochemistry segment accounted for the largest revenue shares of the market in 2022, due to immunohistochemistry technique can be distinguished between tumor types with greater specificity.
  • Hospitals segment is holding the largest revenue shares of the market in 2022, due to physicians are implementing tissue diagnostics testing techniques over conventional methods due to its enhanced efficiency and utility.
  • North America holds the largest revenue shares of the market in 2022, due to public programs like the Cancer Prevention and Control Research Network, aiming to reduce cancer incidence.
  • The global key market players include: Abbott, Agilent Technologies, Inc., Bio SB, BioGenex, Becton, Dickinson and Company (BD), Cell Signaling Technology, Inc., Danaher, GE Healthcare, and others.

Polaris Market Research has segmented the Tissue Diagnostics market report based on product, technology, disease, end-use, and region:

Tissue Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Consumables

Tissue Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • In-situ hybridization
  • Primary & Special Staining
  • Immunohistochemistry
  • Digital Pathology
  • Others

Tissue Diagnostics, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Skin Cancer
  • Others

Tissue Diagnostics, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Research Laboratories
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Other

Tissue Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tissue Diagnostics Market Insights

  • 4.1. Tissue Diagnostics - Industry Snapshot
  • 4.2. Tissue Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in imaging techniques and improved diagnostics affordability
      • 4.2.1.2. Growth of personalized therapeutics and diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high costs associated with R&D and clinical trials
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Tissue Diagnostics Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tissue Diagnostics Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. In-situ hybridization
    • 5.3.1. Global Tissue Diagnostics Market, by In-situ hybridization, by Region, 2019-2032 (USD Billion)
  • 5.4. Primary & Special Staining
    • 5.4.1. Global Tissue Diagnostics Market, by Primary & Special Staining, by Region, 2019-2032 (USD Billion)
  • 5.5. Immunohistochemistry
    • 5.5.1. Global Tissue Diagnostics Market, by Immunohistochemistry, by Region, 2019-2032 (USD Billion)
  • 5.6. Digital Pathology
    • 5.6.1. Global Tissue Diagnostics Market, by Digital Pathology, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Tissue Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Tissue Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Tissue Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Consumables
    • 6.4.1. Global Tissue Diagnostics Market, by Consumables, by Region, 2019-2032 (USD Billion)

7. Global Tissue Diagnostics Market, by Disease

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 7.3. Prostate Cancer
    • 7.3.1. Global Tissue Diagnostics Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Breast Cancer
    • 7.4.1. Global Tissue Diagnostics Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Tissue Diagnostics Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Skin Cancer
    • 7.6.1. Global Tissue Diagnostics Market, by Skin Cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Tissue Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Tissue Diagnostics Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Tissue Diagnostics Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Research Laboratories
    • 8.4.1. Global Tissue Diagnostics Market, by Research Laboratories, by Region, 2019-2032 (USD Billion)
  • 8.3. Contract Research Organizations
    • 8.3.1. Global Tissue Diagnostics Market, by Contract Research Organizations, by Region, 2019-2032 (USD Billion)
  • 8.4. Pharmaceutical Companies
    • 8.4.1. Global Tissue Diagnostics Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
  • 8.3. Other
    • 8.3.1. Global Tissue Diagnostics Market, by Other, by Region, 2019-2032 (USD Billion)

9. Global Tissue Diagnostics Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Tissue Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Tissue Diagnostics Market - North America
    • 9.3.1. North America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.3.2. North America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.3.4. North America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.3.5. Tissue Diagnostics Market - U.S.
      • 9.3.5.1. U.S.: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.3.6. Tissue Diagnostics Market - Canada
      • 9.3.6.1. Canada: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.4. Tissue Diagnostics Market - Europe
    • 9.4.1. Europe: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.5. Tissue Diagnostics Market - UK
      • 9.4.5.1. UK: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.6. Tissue Diagnostics Market - France
      • 9.4.6.1. France: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.7. Tissue Diagnostics Market - Germany
      • 9.4.7.1. Germany: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.8. Tissue Diagnostics Market - Italy
      • 9.4.8.1. Italy: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.9. Tissue Diagnostics Market - Spain
      • 9.4.9.1. Spain: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.10. Tissue Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.11. Tissue Diagnostics Market - Russia
      • 9.4.11.1. Russia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.5. Tissue Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.5. Tissue Diagnostics Market - China
      • 9.5.5.1. China: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.6. Tissue Diagnostics Market - India
      • 9.5.6.1. India: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.7. Tissue Diagnostics Market - Japan
      • 9.5.7.1. Japan: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.8. Tissue Diagnostics Market - Malaysia
      • 9.5.8.1. Malaysia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.9. Tissue Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.10. Tissue Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.6. Tissue Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.5. Tissue Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.6. Tissue Diagnostics Market - South Africa
      • 9.6.6.1. South Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.7. Tissue Diagnostics Market - Israel
      • 9.6.7.1. Israel: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.8. Tissue Diagnostics Market - UAE
      • 9.6.8.1. UAE: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.7. Tissue Diagnostics Market - Latin America
    • 9.7.1. Latin America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.5. Tissue Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.6. Tissue Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.7. Tissue Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bio SB
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BioGenex
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Becton, Dickinson and Company (BD)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Cell Signaling Technology, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Danaher
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. GE Healthcare
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Histo-Line Laboratories
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Hologic Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Merck KGAA
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Metropolis Healthcare Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Roche
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. SAKURA FINETEK JAPAN CO., LTD
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. SLEE Medical GMBH
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Thermo Fisher Scientific Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development

List of Tables

  • Table 1 Global Tissue Diagnostics Market, by Technology, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Tissue Diagnostics Market, by Product, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Tissue Diagnostics Market, by Disease, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Tissue Diagnostics Market, by End-Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Tissue Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 North America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 8 North America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 9 North America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 U.S.: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 12 U.S.: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 13 U.S.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Canada: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Canada: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 17 Canada: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Europe: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Europe: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 21 Europe: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 25 Germany: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 France: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 France: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 France: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 29 France: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 30 UK: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 UK: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 32 UK: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 33 UK: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Italy: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Italy: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 37 Italy: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Spain: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 44 Spain: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 45 Spain: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Russia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Russia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 49 Russia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 54 China: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 China: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 56 China: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 57 China: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Japan: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Japan: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 61 Japan: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 India: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 India: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 64 India: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 65 India: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 South Korea: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 76 South Korea: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 77 South Korea: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 79 Latin America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 80 Latin America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 81 Latin America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Brazil: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Brazil: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 85 Brazil: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 87 Mexico: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 88 Mexico: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 89 Mexico: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 91 Argentina: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 92 Argentina: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 93 Argentina: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 99 UAE: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 100 UAE: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 101 UAE: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 107 South Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 108 South Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 109 South Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 111 Israel: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 112 Israel: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 113 Israel: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Tissue Diagnostics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End-Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Tissue Diagnostics Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End-Use
  • Figure 9. Global Tissue Diagnostics Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Product
  • Figure 11. Global Tissue Diagnostics Market, by Product, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Disease
  • Figure 13. Global Tissue Diagnostics Market, by Disease, 2021 & 2030 (USD Billion)